Alamar Biosciences Inc. logo

Alamar Biosciences Inc.

ALMR | NASDAQ
Chart Builder DCF Calculator
$29.10
-$1.50 (-4.90%)
Nov 2, 2026, 1:16 PM ET · Market open

Market Data

Market Cap
$2.02B
Enterprise Value
$1.92B
Beta
-6.18
Average Volume
490K
Shares Outstanding (Diluted)
58.67M
Shares Change YoY
N/A
Institutional Ownership
35.54%
Exchange
NASDAQ
ISIN
US0109111056

Price Performance

Price Change 1M
-15.3%
Price Change 3M
7.5%
Price Change 6M
22.5%
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
-12.2%
1Y CAGR (ann.)
N/A
5Y CAGR (ann.)
N/A
All-Time CAGR
84.9%

Valuation

PE Ratio
-57.74
Forward PE
N/A
PEG Ratio
-0.58
Forward PEG
1.27
PS Ratio
38.29
Forward PS
12.80
PB Ratio
6.79
P/FCF Ratio
-59.13
P/Adj. FCF Ratio
-59.13
P/OCF Ratio
-56.67
EV/Sales
34.70
EV/EBIT
-57.10
EV/EBITDA
-59.15
EV/FCF
-53.60
Earnings Yield
-1.7%
FCF Yield
-1.7%
Adj. FCF Yield
-1.7%

Financial Health

Net Cash
$237.83M
Total Debt
$51.41M
Cash & Short-Term Investments
$250.05M
Total Assets
$390.98M
Current Ratio
11.85
Quick Ratio
10.23
Debt / Equity Ratio
0.16
Debt / EBITDA
-1.58
Debt / FCF
-1.43
OCF / Debt
-0.62
Interest Coverage
-57.89
Altman Z-Score
16.37
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
58.0%
Operating Profit Margin
-46.7%
EBITDA Margin
-56.6%
Net Profit Margin
-62.3%
FCF Margin
-64.8%
Adj. FCF Margin
-64.8%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-8.8%
Return on Equity
428.6%
Return on Invested Capital
-7.1%
Return on Capital Employed
-7.1%
Return on Tangible Assets
-8.9%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
2
EPS Growth Next 3Y
37.7%
Revenue Growth Next 3Y
75.1%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.20
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$30.22M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$33.50
Price Target Upside
9.5%

Cash Flow

Operating Cash Flow
$-31.67M
Free Cash Flow
$-35.91M
Adj. Free Cash Flow
$-35.91M
FCF Per Share
-$0.61
OCF Per Share
-$0.54
OCF/S Ratio
-57.1%

Income Statement

Revenue
$55.46M
Gross Profit
$32.18M
Operating Income
$-25.88M
EBITDA
$-32.54M
Net Income
$-34.52M
EPS (Diluted)
-$0.53
Revenue / Employee
$249.83K
Profit / Employee
$-155.51K
Employees
222

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.